| abstract |
The present invention relates to a novel compound represented by the formula (I). The compounds may be used in combination with one or more kinases, particularly Spleen Tyrosine Kinase (SYK), Leucine-rich repeat kinase (LRRK2) and / or Myosin light (MYLK) chain kinase) or mutations thereof. The compound can be applied to the treatment of various diseases. The disease is selected from the group consisting of autoimmune diseases, inflammatory diseases, bone diseases, metabolic diseases, neurodegenerative diseases, cancer, cardiovascular diseases, allergies, asthma, Alzheimer's disease, Parkinson's disease, skin diseases, ophthalmic diseases, . |